Brazilian pharmaceutical company applies to regulator for permit to urgently use Sputnik V
RIO DE JANEIRO, January 16. /TASS/: Brazil’s pharmaceutical company Uniao Quimica and the Russian Direct Investment Fund (RDIF) submitted an application on Friday to the Brazilian national sanitary watchdog Anvisa for permit to urgently use the Russian Sputnik V vaccine against the coronavirus, the company said in a statement.